Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Burden of risk variants correlates with phenotype of multiple sclerosis.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
Acute Disseminated Encephalomyelitis.
Quantitative proteome profiling of CNS-infiltrating autoreactive CD4(+) cells reveals selective changes during experimental autoimmune encephalomyelitis.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
Bilateral Optic Neuritis-The Only Ocular Finding in a Case of Subacute Sclerosing Panencephalitis.
Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.
Walking and cognition, but not symptoms, correlate with dual task cost of walking in multiple sclerosis.
Application of multispectral imaging detects areas with neuronal myelin loss, without tissue labelling.
JC Virus Replication at the First Symptoms of Multiple Sclerosis: A Case Report.
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.
Health-related quality of life among latinos with multiple sclerosis.
An early British case of neuromyelitis optica (1850).
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
FLAIR*: A Combined MR Contrast Technique for Visualizing White Matter Lesions and Parenchymal Veins.
[Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis].
[Acute disseminated encephalomyelitis and multiple sclerosis: open questions of differential diagnosis demonstrated by the example of a clinical case.]
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study.

Pages